In This Story VKTX -9.01% NVO -1.43% LLY -0.81% Viking Therapeutics ( VKTX -9.01% ), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm. Suggested Reading DeepSeek's founder isn't interested in investors for now Is a recession coming? Here's what JPMorgan and other banks, analysts, and economists say The Dow drops 550 points as Trump shrugs off a market rout and says more tariffs are coming